Daiwa Securities Group Inc. - CHINA BIOLOGIC PRODS HLDGS I ownership

CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2021. The put-call ratio across all filers is 0.04 and the average weighting 0.8%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$9,0000.0%77
+5.5%
0.00%
Q4 2020$9,000
-62.5%
73
-66.4%
0.00%
Q3 2020$24,000
-25.0%
2170.0%0.00%
-100.0%
Q2 2020$32,000
+39.1%
2170.0%0.00%
Q1 2020$23,000
-8.0%
2170.0%0.00%
Q4 2019$25,000
-10.7%
217
-11.1%
0.00%
Q3 2019$28,000
+16.7%
244
-2.4%
0.00%
Q2 2019$24,000
+4.3%
2500.0%0.00%
Q1 2019$23,000
+9.5%
250
-8.4%
0.00%
Q4 2018$21,000
+75.0%
273
+78.4%
0.00%
Q3 2018$12,000
-20.0%
1530.0%0.00%
Q2 2018$15,000
+25.0%
1530.0%0.00%
Q1 2018$12,0001530.00%
Other shareholders

There were no reported owners of CHINA BIOLOGIC PRODS HLDGS I in Q1 2021.

NameSharesValueWeighting ↓
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders